Literature DB >> 26358893

Lipidomics of human brain aging and Alzheimer's disease pathology.

Alba Naudí1, Rosanna Cabré1, Mariona Jové1, Victoria Ayala1, Hugo Gonzalo1, Manuel Portero-Otín1, Isidre Ferrer2, Reinald Pamplona3.   

Abstract

Lipids stimulated and favored the evolution of the brain. Adult human brain contains a large amount of lipids, and the largest diversity of lipid classes and lipid molecular species. Lipidomics is defined as "the full characterization of lipid molecular species and of their biological roles with respect to expression of proteins involved in lipid metabolism and function, including gene regulation." Therefore, the study of brain lipidomics can help to unravel the diversity and to disclose the specificity of these lipid traits and its alterations in neural (neurons and glial) cells, groups of neural cells, brain, and fluids such as cerebrospinal fluid and plasma, thus helping to uncover potential biomarkers of human brain aging and Alzheimer disease. This review will discuss the lipid composition of the adult human brain. We first consider a brief approach to lipid definition, classification, and tools for analysis from the new point of view that has emerged with lipidomics, and then turn to the lipid profiles in human brain and how lipids affect brain function. Finally, we focus on the current status of lipidomics findings in human brain aging and Alzheimer's disease pathology. Neurolipidomics will increase knowledge about physiological and pathological functions of brain cells and will place the concept of selective neuronal vulnerability in a lipid context.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Alzheimer's disease; Docosahexaenoic acid; Human brain; Lipid peroxidation; Lipidomics

Mesh:

Substances:

Year:  2015        PMID: 26358893     DOI: 10.1016/bs.irn.2015.05.008

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  43 in total

Review 1.  Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.

Authors:  Marcus O W Grimm; Daniel M Michaelson; Tobias Hartmann
Journal:  J Lipid Res       Date:  2017-05-20       Impact factor: 5.922

Review 2.  Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.

Authors:  Yunhua Peng; Peipei Gao; Le Shi; Lei Chen; Jiankang Liu; Jiangang Long
Journal:  Antioxid Redox Signal       Date:  2020-03-16       Impact factor: 8.401

3.  Occult hypoperfusion and changes of systemic lipid levels after severe trauma: an analysis in a standardized porcine polytrauma model.

Authors:  Yohei Kumabe; Yannik Kalbas; Sascha Halvachizadeh; Michel Teuben; Nikola Cesarovic; Miriam Weisskopf; Andreas Hülsmeier; Thorsten Hornemann; Paolo Cinelli; Hans-Christoph Pape; Roman Pfeifer
Journal:  Eur J Trauma Emerg Surg       Date:  2022-07-12       Impact factor: 2.374

4.  Lipids and EGCG Affect α-Synuclein Association and Disruption of Nanodiscs.

Authors:  Henry M Sanders; Marius M Kostelic; Ciara K Zak; Michael T Marty
Journal:  Biochemistry       Date:  2022-05-26       Impact factor: 3.321

5.  Effects of Sevoflurane Anesthesia on Cerebral Lipid Metabolism in the Aged Brain of Marmosets and Mice.

Authors:  Haoli Mao; Jiao Zhu; Yanyong Cheng; Lingling Shi; Xiao Chen; Ren Zhou; Zhenyu Xue; Siyu Liu; Zilong Qiu; Hong Jiang
Journal:  Front Mol Neurosci       Date:  2022-07-06       Impact factor: 6.261

6.  Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease.

Authors:  Richard D Semba
Journal:  Adv Nutr       Date:  2020-07-01       Impact factor: 8.701

7.  Alteration in the Cerebrospinal Fluid Lipidome in Parkinson's Disease: A Post-Mortem Pilot Study.

Authors:  Joaquín Fernández-Irigoyen; Paz Cartas-Cejudo; Marta Iruarrizaga-Lejarreta; Enrique Santamaría
Journal:  Biomedicines       Date:  2021-04-29

Review 8.  Cardiolipin, Mitochondria, and Neurological Disease.

Authors:  Micol Falabella; Hilary J Vernon; Michael G Hanna; Steven M Claypool; Robert D S Pitceathly
Journal:  Trends Endocrinol Metab       Date:  2021-02-24       Impact factor: 12.015

9.  Structural and mechanistic insights into amyloid-β and α-synuclein fibril formation and polyphenol inhibitor efficacy in phospholipid bilayers.

Authors:  Henry M Sanders; Blagojce Jovcevski; Michael T Marty; Tara L Pukala
Journal:  FEBS J       Date:  2021-07-26       Impact factor: 5.542

10.  Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment.

Authors:  Pol Andrés-Benito; Ellen Gelpi; Mariona Jové; Natalia Mota-Martorell; Èlia Obis; Manuel Portero-Otin; Mònica Povedano; Aurora Pujol; Reinald Pamplona; Isidro Ferrer
Journal:  Neuropathol Appl Neurobiol       Date:  2021-01-12       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.